Bizarre Patents
Combination Beverage Container and Spittoon
A combination beverage container and spittoon includes a bottom portion including outer wall and a first inner wall defining a spittoon space.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8163698 | Dolastatin 15 derivatives Compounds of the present invention include cell growth inhibitors which are peptides of Formula I, A-B-D-E-F-(G)r-(K)s-L (I), and acid salts thereof, wherein A, B, D, E, F, G and K are α-amino acid residues, and s and ... | 04/24/2012 |
| 8034776 | Materials and methods for the treatment of celiac disease The present invention provides materials and methods for the treatment of celiac disease. In addition, the present invention provides materials and methods of monitoring the treatment of a subject having celiac disease. ... | 10/11/2011 |
| 8012935 | Synthetic peptides and methods for treating cancer invasion and metastasis The present invention relates to synthetic oligopeptides that exhibit inhibitory activity towards cancer invasion and metastasis. The peptides of the invention comprise PRKPKWDK (SEQ ID:2) peptide corresponding to amino acids of 85 to 92 of the matrix metalloprotein... | 09/06/2011 |
| 7985734 | Peptides for preventing or treating liver damage The application of a peptide having sequence of formula I or its derivant in preparing the medicine for preventing or treating liver damage, especially liver damage and hepatitis C is disclosed, Xaa1-Gln-Xaa2-Xaa3-Thr-Ser-Gly-Xaa4 (formula I) wherein, Xaa1 is deleti... | 07/26/2011 |
| 7816325 | Secondary binding site of dipeptidyl peptidase IV (DP IV) The present application relates to the secondary binding site of dipeptidyl peptidase IV, its relationship amongst substrates and to the modulation of substrate specificity of dipeptidyl peptidase IV (DP IV, synonym: DPP IV, CD26, EC 3.4.14.5). The application relat... | 10/19/2010 |
| 7811995 | Therapeutic and diagnostic peptides This invention generally relates to peptides useful for medical diagnosis and treatment of pathogenic disorders. More specifically, the invention relates to immunostimulatory peptides which can stimulate the production of therapeutically beneficial cytokines and, in... | 10/12/2010 |
| 7803773 | Controlled release formulations of octreotide A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decr... | 09/28/2010 |
| 7786084 | Treatment of burns The invention relates to the treatment of burn injuries. Described are methods for modulating a burn injury in a subject, the method comprising providing the subject with a gene-regulatory peptide or functional analogue thereof, e.g., LQG, AQG, LQGV (SEQ ID NO:1), A... | 08/31/2010 |
| 7786085 | Method for treating a patient undergoing chemotherapy The present invention provides improved methods, kits, and pharmaceutical compositions for increasing hematopoietic cell survival and/or reducing or preventing the side effects of chemotherapy, and mobilizing hematopoietic progenitor cells from bone marrow into peri... | 08/31/2010 |
| 7776828 | Radiation therapy methods The present invention provides methods and kits for mitigating radiation induced tissue damage, improving the effectiveness of radiation therapy, to support bone marrow transplantation, and promoting megakaryocyte production and mobilization and platelet production,... | 08/17/2010 |
| 7772189 | Phage displayed cell binding peptides This disclosure provides the construction, expression, and selection of the mutated genes that encode novel Trp cage polypeptides with desirable binding properties, as well as the novel Trp cage polypeptides themselves. The substances or targets bound by these novel... | 08/10/2010 |
| 7759311 | Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders A pharmaceutical composition comprising a peptide consisting of Arg-Val-Ala-Val-Ile-Met-Gly-amide-having at least one D-amino acid. ... | 07/20/2010 |
| 7759312 | Delivery of dry formulations of octreotide Methods and devices are described for delivering octreotide to a patient, comprising implanting a controlled release composition for delivering octreotide, wherein the composition does not require hydration prior to implantation, and wherein the composition optional... | 07/20/2010 |
| 7754691 | Linear melanocortin receptor-specific peptides for cachexia Linear peptides with a C-terminus —OH group that are specific for one or more melanocortin receptors, and which may be used in the treatment of melanocortin receptor-mediated disorders, including a variety of body weight disorders including cachexia, and for treat... | 07/13/2010 |
| 7749968 | Peptides for targeting the prostate specific membrane antigen The invention provides isolated PSMA binding peptides, as well as pharmaceutical compositions thereof. Also provided are diagnostic and therapeutic methods utilizing the PSMA binding peptides, as well as methods for identifying further PSMA binding peptides. ... | 07/06/2010 |
| 7745412 | Isozyme-specific antagonists of protein kinase C A method of changing or otherwise converting the biological activity of a PKC peptide agonist to a peptide antagonist is described. The method involves substituting one or more amino acid residues so as to effect a change in charge in the peptide and/or to otherwise... | 06/29/2010 |
| 7745411 | Methods for promoting erythropoiesis The present invention provides methods, compounds, pharmaceutical compositions, and kits for the augmentation of erythropoiesis by potentiating erythropoietin-induced differentiation with angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues ... | 06/29/2010 |
| 7741292 | Method of inhibiting the emigration of cells from the intravascular compartment into tissues A method of inhibiting the emigration of cells from the intravascular compartment into tissues (or through any membrane limiting any body compartment from another) by confronting the cells with an agonist specific for receptors involved with migration of said cells ... | 06/22/2010 |
| 7741290 | Method of preventing progression of hypertension-induced heart failure with PKC peptides Methods are described for slowing or inhibiting the progression of heart failure in a mammalian subject suffering from chronic hypertension. The methods involve administering an εPKC, β1PKC, or βIIPKC peptide inhibitor, examples of which are provided. ... | 06/22/2010 |
| 7723304 | Systems for delivery and release of angiotensin-(1-7) The prior art lacks a formulation, application or product of D-Ala7-Angiotensin-(1-7) (A-779) and analogues and derivatives, D-Pro7-Angiotensin-(1-7) and analogues or derivatives or of Ang-(1-7) analogues or derivatives using cyclodextrins, liposomes, biodegradable ... | 05/25/2010 |
| 7687465 | Therapeutic cancer vaccine The present invention relates to polypeptides capable of raising a specific T-cell response, wherein the polypeptide comprises a peptide consisting of at least 9 consecutive amino acid residues of ML-IAP, as well as to the use of such polypeptides as medicaments. Th... | 03/30/2010 |
| 7674773 | Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use Compounds of the formula I, in which R1, R2, R3, R4, R5, and R6 have the meanings given in the description, and their physiologically acceptable salts. The compounds are suitable for use, for example, as hypolipidemics. | 03/09/2010 |
| 7666842 | Elastin peptide analogs and uses thereof Compositions used to enhance the elasticity and/or appearance of tissue are described. The compositions include peptides and/or peptide-like compounds and combinations thereof having low molecular weights and which substantially correspond to sequences found in elas... | 02/23/2010 |
| 7662784 | Method for decreasing body weight using a somatostatin receptor agonist The present invention relates to a method of decreasing body weight in a patient. The method includes the step of administering a therapeutically effective amount of a somatostatin or a somatostatin agonist to said patient. A pharmaceutical/cosmetic composition comp... | 02/16/2010 |
| 7629318 | Immunosuppressant compounds, methods and uses related thereto The present invention relates to compositions and methods for suppressing an immune response, e.g., by inhibiting class II MHC-mediated activation of T cells. The subject compounds and methods may be used to treat or prevent disorders such as rheumatoid arthritis an... | 12/08/2009 |
| 7605133 | Isolated peptides to treat alpha-synuclein diseases The present invention relates to drug screening methods and methods of preventing neural tissue damage caused by α-synuclein aggregation. These methods are especially useful in the design and development of inhibitors of Lewy body diseases and other synucleinopathi... | 10/20/2009 |
| 7589064 | Formulations of ramipril The present invention relates to stable tablet formulations of ramipril, optionally in combination with a diuretic. ... | 09/15/2009 |
| 7579321 | Pharmaceutical compositions including low dosages of desmopressin The present invention is directed to a pharmaceutical composition comprising 0.5 ng to 20 μg desmopressin and a pharmaceutically acceptable carrier. The present invention is also directed to a pharmaceutical composition comprising desmopressin and a pharmaceuticall... | 08/25/2009 |
| 7563772 | Methods of increasing cerebral blood flow Methods of increasing blood flow in a mammalian brain blood vessel characterized by, or otherwise experiencing, decreased blood flow due to an ischemic or other hypoxic event, vasoconstriction or vasospasm following hemorrhagic stroke; due to chronic high blood pres... | 07/21/2009 |
| 7557087 | Compositions and methods for treating diseases This invention relates to compositions and methods for treatment of vascular conditions. The invention provides arginine polymers and arginine homopolymers for the treatment and/or prevention of glaucoma, pulmonary hypertension, asthma, chronic obstructive pulmonary... | 07/07/2009 |
| 7531516 | Peptidic compounds selectively binding to P-selectin The present invention relates to compounds which bind selectively to the adhesion molecule human P-selectin, and particularly to such compounds comprising a peptide with an amino acid sequence XAxA3A1A2A1Y, or a... | 05/12/2009 |
| 7521426 | HIV-specific CTL inducing peptides and medicaments for preventing or treating AIDS comprising the peptides Peptides which can induce specific CTLs for HIV, DNAs encoding for the peptides and medicaments for preventing and/or treating HIV comprising the peptides are provided. According to the present invention, peptides carrying novel CTL epitopes derived from HIV Pol or ... | 04/21/2009 |
| 7514408 | β-secretase enzyme compositions and methods Disclosed is an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that p... | 04/07/2009 |
| 7465709 | Structural formulas based on the repetitive motifs of salivary proline rich proteins mucin and collagen designed to modulate cell and tissue growth division and differentiation Computational analysis was used to derive structural peptide formulas SALIVAR, SALIVAL, SALIVAN characterizing common repetitive fragments that reconstruct a large number of salivary proline rich proteins. Short repetitive sequences and variants of the mucin (MUKOSE... | 12/16/2008 |
| 7452868 | Controlled release formulations of octreotide A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decr... | 11/18/2008 |
| 7435790 | Dihydroxypropyl cysteine peptide and agent containing this peptide The invention relates to a S-(2,3-dihydroxypropyl)-cysteine peptide which has two long-chain fatty acids bonded in the form of esters at the dihydroxypropyl group, and which has the following sequence: DhcGN NDE SNI SFK EK. The invention relat... | 10/14/2008 |
| 7432245 | Pharmaceutical formulation comprising a peptide angiogenesis inhibitor Parenteral formulations of peptides which are useful for sustained release are disclosed. Also disclosed are methods of preparation for the formulations. ... | 10/07/2008 |
| 7427598 | Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory The present invention provides methods for improving performance (e.g. learning and/or memory) using (ADNF) polypeptides, by treating the subject prenatally or postnatally with an Activity Dependent Neurotrophic Factor (ADNF) polypeptide in an amount sufficient to i... | 09/23/2008 |
| 7425541 | Enzyme-cleavable prodrug compounds The prodrug of the invention is a modified form of a therapeutic agent and comprises a therapeutic agent, an oligopeptide, a stabilizing group and, optionally, a linker group. The prodrug is cleavable by the enzyme Thimet oligopeptidase, or TOP. Also disclosed are m... | 09/16/2008 |
| 7423020 | Treatment of mood disorders by administration of SMR1 This invention relates to the use of an agent that modulates the interaction between a SMR1 peptide and a metal-lopeptidase for the preparation of a medicament for preventing or treating a Central Nervous System disorder giving rise to a mental disorder. ... | 09/09/2008 |
